Neuphoria Therapeutics In... (NEUP)
NASDAQ: NEUP
· Real-Time Price · USD
7.23
0.29 (4.18%)
At close: Aug 21, 2025, 11:19 AM
Neuphoria Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
July - June.
| Fiscal Year | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 |
Net Income | 11.26M | -1.94M | -805K | -2.69M | n/a | -4.55M | -5.47M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Depreciation & Amortization | 165.43K | 166.12K | 165.71K | 165.69K | n/a | 165.69K | 165.91K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 19.68K | 19.08K | 26.74K | 107.72K | n/a | 556.98K | 132.74K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | 131.84K | -613.23K | -291.86K | 614.76K | -250.54K | 334.68K | -348.28K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Non-Cash Items | 648.69K | -1.27M | -2.62M | -2.85M | -2.19M | 98.96K | 228.04K | n/a | -5.33M | -4.02M | -2.11M | n/a | -2.73M | -5.52M | -3.78M | -3.19M | -1.77M | 934.16K | -2.1M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -642.52K | -328K | -1.2M | 2.26M | -1.11M | -212.34K | 516.08K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Cash Flow | 11.45M | -3.36M | -4.43M | -3.01M | -3.3M | -3.95M | -4.43M | n/a | -5.33M | -4.02M | -2.11M | n/a | -2.73M | -5.52M | -3.78M | -3.19M | -1.77M | 934.16K | -2.1M |
Capital Expenditures | n/a | n/a | 3.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -89.41K | n/a | 768.86 | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 187.41K | n/a | 130K | n/a | -29.01K | -1.5K | 319.74K | 125.58K | -11.27K | n/a | 12.3K | 23.57K |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 187.41K | n/a | 130K | n/a | -29.01K | -1.5K | 319.74K | 125.58K | -100.68K | n/a | 13.07K | 23.57K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -25.28K | -26.86K | -28.41K | -25.39K | n/a | n/a | -27.2K | -44.49K | -6.06M | -1.35M | -962.61K | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 34.11K | n/a | n/a | 5M | -38.71K | 5.34M | -5.65M | -141.75K | -178.63K | -942.72K | n/a | -104.64K | -249.72K | -2.05M | -841.75K | -111.95K | -28.91K | -148.39K | -25.72K |
Financial Cash Flow | 1.16M | -107.1K | -227K | 7.12M | 1.75M | 5.63M | 612.54K | -167.03K | -205.49K | 4.08M | -25.39K | -2.14M | 2.92M | 18.68M | -866.86K | 9.47M | 12.83M | 245.26K | 1.82M |
Net Cash Flow | 12.7M | -3.75M | -4.52M | 4.18M | -1.73M | 2.02M | -3.97M | -2.99M | -5.54M | 425.6K | -1.39M | -6.59M | -575.92K | 13.34M | -4.54M | 6.13M | 11.11M | 1.14M | -228.59K |
Free Cash Flow | 11.22M | -3.36M | -4.43M | -3.01M | -3.3M | -3.95M | -4.43M | -2.67M | -5.33M | -4.02M | -2.11M | -3.24M | -2.73M | -5.52M | -3.78M | -3.19M | -1.77M | 934.16K | -2.1M |